# Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

> **NCT06798727** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Medipost Co Ltd.** · enrollment: 84 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** SMUP-IA-01(low-dose)
- **BIOLOGICAL:** SMUP-IA-01(mid-dose)
- **DRUG:** High Hyal Plus

## Key facts

- **NCT ID:** NCT06798727
- **Lead sponsor:** Medipost Co Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-20
- **Primary completion:** 2027-03-20
- **Final completion:** 2027-11-30
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798727, "Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06798727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*